{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T18:57:00Z","timestamp":1766516220233,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T00:00:00Z","timestamp":1718496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1007\/s12328-024-02003-z","type":"journal-article","created":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T19:01:22Z","timestamp":1718564482000},"page":"844-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Secondary amyloidosis in inflammatory bowel disease patients: findings from three tertiary medical centers"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5214-7923","authenticated-orcid":false,"given":"Vikram S.","family":"Gill","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayi P.","family":"Boddu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sami","family":"Abujbarah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie L.","family":"Mathis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Merchea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,16]]},"reference":[{"key":"2003_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.14797\/mdcj-8-3-3","volume":"8","author":"KR Baker","year":"2012","unstructured":"Baker KR, Rice L. The Amyloidoses: clinical features, diagnosis and treatment. Methodist Debakey Cardiovasc J. 2012;8:3\u20137.","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2003_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","volume":"7","author":"S Urieli-Shoval","year":"2000","unstructured":"Urieli-Shoval S, Linke RP, Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol. 2000;7:64\u20139.","journal-title":"Curr Opin Hematol"},{"key":"2003_CR3","doi-asserted-by":"publisher","first-page":"369","DOI":"10.2147\/CLEP.S39981","volume":"6","author":"D Real de As\u00faa","year":"2014","unstructured":"Real de As\u00faa D, Costa R, Galv\u00e1n JM, et al. Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol. 2014;6:369\u201377. https:\/\/doi.org\/10.2147\/CLEP.S39981.","journal-title":"Clin Epidemiol"},{"key":"2003_CR4","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJB, Gilbertson JA, et al. Natural history and outcome in systemic AA Amyloidosis. N Engl J Med. 2007;356:2361\u201371.","journal-title":"N Engl J Med"},{"key":"2003_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1111\/bjh.12286","volume":"161","author":"JH Pinney","year":"2013","unstructured":"Pinney JH, Smith CJ, Taube JB, et al. Systemic amyloidosis in England: an epidemiological study. Br J Haematol. 2013;161:525\u201332.","journal-title":"Br J Haematol"},{"key":"2003_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/1471-2458-12-974","volume":"12","author":"K Hemminki","year":"2012","unstructured":"Hemminki K, Li X, F\u00f6rsti A, et al. Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health. 2012;12:974.","journal-title":"BMC Public Health"},{"key":"2003_CR7","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116\u201322.","journal-title":"Am J Gastroenterol"},{"key":"2003_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00054725-200111000-00003","volume":"7","author":"AL Wester","year":"2001","unstructured":"Wester AL, Vatn MH, Fausa O. Secondary amyloidosis in inflammatory bowel disease: a study of 18 patients admitted to Rikshospitalet university hospital, Oslo, from 1962 to 1998. Inflamm Bowel Dis. 2001;7:295\u2013300.","journal-title":"Inflamm Bowel Dis"},{"key":"2003_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00005792-199209000-00001","volume":"71","author":"AJ Greenstein","year":"1992","unstructured":"Greenstein AJ, Sachar DB, Panday AK, et al. Amyloidosis and inflammatory bowel disease. a 50-year experience with 25 patients. Medicine (Baltimore). 1992;71:261\u201370.","journal-title":"Medicine (Baltimore)"},{"key":"2003_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/gut.31.12.1387","volume":"31","author":"IT Weterman","year":"1990","unstructured":"Weterman IT, Biemond I, Pe\u00f1a AS. Mortality and causes of death in Crohn\u2019s disease. review of 50 years\u2019 experience in Leiden university hospital. Gut. 1990;31:1387\u201390.","journal-title":"Gut"},{"key":"2003_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/00365527709181699","volume":"12","author":"O Fausa","year":"1977","unstructured":"Fausa O, Nygaard K, Elgjo K. Amyloidosis and Crohn\u2019s Disease. Scand J Gastroenterol. 1977;12:657\u201362.","journal-title":"Scand J Gastroenterol"},{"key":"2003_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.crohns.2009.11.009","volume":"4","author":"I Serra","year":"2010","unstructured":"Serra I, Oller B, Ma\u00f1osa M, et al. Systemic amyloidosis in inflammatory bowel disease: retrospective study on its prevalence, clinical presentation, and outcome. J Crohns Colitis. 2010;4:269\u201374.","journal-title":"J Crohns Colitis"},{"key":"2003_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1093\/ecco-jcc\/jjw080","volume":"10","author":"J Tosca Cuquerella","year":"2016","unstructured":"Tosca Cuquerella J, Bosca-Watts MM, Anton Ausejo R, et al. Amyloidosis in inflammatory Bowel disease: a systematic review of epidemiology, clinical features, and treatment. J Crohn\u2019s Colitis. 2016;10:1245\u201353.","journal-title":"J Crohn\u2019s Colitis"},{"key":"2003_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/S0755-4982(04)98773-8","volume":"33","author":"S B\u00e9ji","year":"2004","unstructured":"B\u00e9ji S, Kaaroud H, Ben Moussa F, et al. Renal amyloidosis complicating the outcome of chronic inflammatory colitis. Presse Med. 2004;33:862\u20135.","journal-title":"Presse Med"},{"key":"2003_CR15","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4321\/S1130-01082011000500009","volume":"103","author":"A Guardiola-Ar\u00e9valo","year":"2011","unstructured":"Guardiola-Ar\u00e9valo A, Alc\u00e1ntara-Torres M, Valle-Mu\u00f1oz J, et al. Amyloidosis and Crohn\u00b4s disease. Rev Esp Enferm Dig. 2011;103:268\u201374.","journal-title":"Rev Esp Enferm Dig"},{"key":"2003_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/eci.12045","volume":"43","author":"MA Denis","year":"2013","unstructured":"Denis MA, Cosyns J-P, Persu A, et al. Control of AA amyloidosis complicating Crohn\u2019s disease: a clinico-pathological study. Eur J Clin Invest. 2013;43:292\u2013301.","journal-title":"Eur J Clin Invest"},{"key":"2003_CR17","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s10620-012-2549-x","volume":"58","author":"PT Sattianayagam","year":"2013","unstructured":"Sattianayagam PT, Gillmore JD, Pinney JH, et al. Inflammatory Bowel disease and systemic AA Amyloidosis. Dig Dis Sci. 2013;58:1689\u201397.","journal-title":"Dig Dis Sci"},{"key":"2003_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.661101","author":"P Eriksson","year":"2021","unstructured":"Eriksson P, M\u00f6lne J, Wirestam L, et al. Successful Treatment of AA Amyloidosis in ankylosing Spondylitis using Tocilizumab: report of two cases and review of the literature. Front Med. 2021. https:\/\/doi.org\/10.3389\/fmed.2021.661101.","journal-title":"Front Med"},{"key":"2003_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.765474","author":"Z Cai","year":"2021","unstructured":"Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med. 2021. https:\/\/doi.org\/10.3389\/fmed.2021.765474.","journal-title":"Front Med"},{"key":"2003_CR20","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.crohns.2011.06.002","volume":"5","author":"Y Mazor","year":"2011","unstructured":"Mazor Y, Maza I, Kaufman E, et al. Prediction of disease complication occurrence in Crohn\u2019s disease using phenotype and genotype parameters at diagnosis. J Crohns Colitis. 2011;5:592\u20137.","journal-title":"J Crohns Colitis"},{"key":"2003_CR21","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/ibd\/izy004","volume":"24","author":"M Severs","year":"2018","unstructured":"Severs M, Spekhorst LM, Mangen M-JJ, et al. Sex-related differences in patients with inflammatory Bowel disease: results of 2 prospective cohort studies. Inflamm Bowel Dis. 2018;24:1298\u2013306.","journal-title":"Inflamm Bowel Dis"},{"key":"2003_CR22","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1038\/ajg.2012.298","volume":"107","author":"L Peyrin-Biroulet","year":"2012","unstructured":"Peyrin-Biroulet L, Harmsen WS, Tremaine WJ, et al. Surgery in a population-based cohort of Crohn\u2019s disease from Olmsted county, Minnesota (1970\u20132004). Am J Gastroenterol. 2012;107:1693\u2013701.","journal-title":"Am J Gastroenterol"},{"key":"2003_CR23","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/jgh.12352","volume":"29","author":"J Ampuero","year":"2014","unstructured":"Ampuero J, Rojas-Feria M, Castro-Fern\u00e1ndez M, et al. Predictive factors for erythema nodosum and pyoderma gangrenosum in inflammatory bowel disease. J Gastroenterol Hepatol. 2014;29:291\u20135.","journal-title":"J Gastroenterol Hepatol"},{"key":"2003_CR24","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.crohns.2012.08.001","volume":"7","author":"X Wu","year":"2013","unstructured":"Wu X, Mukewar S, Kiran RP, et al. Risk factors for peristomal pyoderma gangrenosum complicating inflammatory bowel disease. J Crohns Colitis. 2013;7:e171-177.","journal-title":"J Crohns Colitis"},{"key":"2003_CR25","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","volume":"23","author":"ML Halling","year":"2017","unstructured":"Halling ML, Kjeldsen J, Knudsen T, et al. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases. World J Gastroenterol. 2017;23:6137\u201346.","journal-title":"World J Gastroenterol"},{"key":"2003_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1443-1661.2010.01069.x","volume":"23","author":"M Miyaoka","year":"2011","unstructured":"Miyaoka M, Matsui T, Hisabe T, et al. Clinical and endoscopic features of amyloidosis secondary to Crohn\u2019s disease: diagnostic value of duodenal observation and biopsy. Dig Endosc. 2011;23:157\u201365.","journal-title":"Dig Endosc"},{"key":"2003_CR27","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1097\/00004836-198806000-00013","volume":"10","author":"R Aronowitz","year":"1988","unstructured":"Aronowitz R, Spiro HM. The rise and fall of the psychosomatic hypothesis in ulcerative colitis. J Clin Gastroenterol. 1988;10:298\u2013305.","journal-title":"J Clin Gastroenterol"},{"key":"2003_CR28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1056\/NEJM198005013021801","volume":"302","author":"DH Present","year":"1980","unstructured":"Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn\u2019s disease with 6-mercaptopurine. a long-term, randomized, double-blind study. N Engl J Med. 1980;302:981\u20137.","journal-title":"N Engl J Med"},{"key":"2003_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11845-017-1666-0","volume":"187","author":"DG Ribaldone","year":"2018","unstructured":"Ribaldone DG, Dileo I, Pellicano R, et al. Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy. Ir J Med Sci. 2018;187:385\u201392.","journal-title":"Ir J Med Sci"},{"key":"2003_CR30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.cgh.2014.07.041","volume":"13","author":"DJ Gibson","year":"2015","unstructured":"Gibson DJ, Heetun ZS, Redmond CE, et al. An accelerated infliximab induction regimen reduces the need for early colectomy in patients with acute severe ulcerative colitis. Clin Gastroenterol Hepatol. 2015;13:330-335.e1.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2003_CR31","volume":"142","author":"L Obici","year":"2012","unstructured":"Obici L, Merlini G. AA amyloidosis: basic knowledge, unmet needs and future treatments. Swiss Med Wkly. 2012;142: w13580.","journal-title":"Swiss Med Wkly"},{"key":"2003_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/13506129.2010.549252","volume":"18","author":"K Immonen","year":"2011","unstructured":"Immonen K, Finne P, Gr\u00f6nhagen-Riska C, et al. A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases - data from nationwide registries in Finland. Amyloid. 2011;18:25\u20138.","journal-title":"Amyloid"},{"key":"2003_CR33","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3390\/pharmaceutics12060539","volume":"12","author":"B Gareb","year":"2020","unstructured":"Gareb B, Otten AT, Frijlink HW, et al. Review: local tumor necrosis factor-\u03b1 inhibition in Inflammatory Bowel disease. Pharmaceutics. 2020;12:539.","journal-title":"Pharmaceutics"},{"key":"2003_CR34","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/BF02554129","volume":"29","author":"CP Lowdell","year":"1986","unstructured":"Lowdell CP, Shousha S, Parkins RA. The incidence of amyloidosis complicating inflammatory bowel disease. a prospective survey of 177 patients. Dis Colon Rectum. 1986;29:351\u20134.","journal-title":"Dis Colon Rectum"},{"key":"2003_CR35","first-page":"504","volume":"30","author":"P Sharma","year":"2017","unstructured":"Sharma P, Aguilar R, Siddiqui OA, et al. Secondary systemic amyloidosis in inflammatory bowel disease: a nationwide analysis. Ann Gastroenterol. 2017;30:504\u201311.","journal-title":"Ann Gastroenterol"},{"key":"2003_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/gut.4.4.299","volume":"4","author":"FC Edwards","year":"1963","unstructured":"Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. Gut. 1963;4:299\u2013308.","journal-title":"Gut"},{"key":"2003_CR37","doi-asserted-by":"publisher","first-page":"66","DOI":"10.5527\/wjn.v5.i1.66","volume":"5","author":"R Scarpioni","year":"2016","unstructured":"Scarpioni R, Ricardi M, Albertazzi V. Secondary amyloidosis in autoinflammatory diseases and the role of inflammation in renal damage. World J Nephrol. 2016;5:66\u201375.","journal-title":"World J Nephrol"},{"key":"2003_CR38","doi-asserted-by":"publisher","first-page":"16115","DOI":"10.1073\/pnas.1306621110","volume":"110","author":"JP Simons","year":"2013","unstructured":"Simons JP, Al-Shawi R, Ellmerich S, et al. Pathogenetic mechanisms of amyloid a amyloidosis. Proc Natl Acad Sci U S A. 2013;110:16115\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2003_CR39","first-page":"25","volume":"56","author":"R Zissin","year":"2005","unstructured":"Zissin R, Hertz M, Osadchy A, et al. Computed tomographic findings of abdominal complications of Crohn\u2019s disease\u2013pictorial essay. Can Assoc Radiol J. 2005;56:25\u201335.","journal-title":"Can Assoc Radiol J"},{"key":"2003_CR40","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/ajg.2014.297","volume":"109","author":"AD Frolkis","year":"2014","unstructured":"Frolkis AD, Lipton DS, Fiest KM, et al. Cumulative incidence of second intestinal resection in Crohn\u2019s disease: a systematic review and meta-analysis of population-based studies. Am J Gastroenterol. 2014;109:1739\u201348.","journal-title":"Am J Gastroenterol"},{"key":"2003_CR41","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1681\/ASN.2006050460","volume":"17","author":"LM Dember","year":"2006","unstructured":"Dember LM. Amyloidosis-associated kidney disease. JASN. 2006;17:3458\u201371.","journal-title":"JASN"},{"key":"2003_CR42","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/jcm8111970","volume":"8","author":"GC Actis","year":"2019","unstructured":"Actis GC, Pellicano R, Fagoonee S, et al. History of Inflammatory Bowel diseases. J Clin Med. 2019;8:1970.","journal-title":"J Clin Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-024-02003-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-024-02003-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T13:18:55Z","timestamp":1727443135000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-024-02003-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,16]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2003"],"URL":"https:\/\/doi.org\/10.1007\/s12328-024-02003-z","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2024,6,16]]},"assertion":[{"value":"6 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"None. This study was deemed IRB Exempt by the Mayo Clinic IRB application number: 22\u2013000668.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}